Evaluating how head position affects pressure in the skull for patients with brain bleeds

Response of Intracranial Pressure Based on Head-of-Bed Positioning in Aneurysmal Subarachnoid Hemorrhage

Not applicable Interventional Milton S. Hershey Medical Center · NCT05604404

This study is testing how different ways of positioning the head can affect pressure inside the skull for patients with brain bleeds.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment15 (estimated)
Ages18 Years and up
SexAll
SponsorMilton S. Hershey Medical Center Academic / other
Locations1 site (Hershey, Pennsylvania)
Trial IDNCT05604404 on ClinicalTrials.gov

What this trial studies

This study aims to assess the impact of different head-of-bed (HOB) positions on intracranial pressure (ICP) in patients suffering from subarachnoid hemorrhage (SAH). It addresses a gap in existing research by focusing specifically on the effects of HOB positioning on ICP, which has not been thoroughly investigated in this patient population. The study will involve patients with confirmed SAH who have ICP monitoring devices, and will compare outcomes across various positions including supine, semi-recumbent, and semi-recumbent with legs flexed. The hypothesis is that certain positions may help lower ICP by promoting venous pooling in the legs.

Who should consider this trial

Good fit: Ideal candidates for this study are adults aged 18 and older with a confirmed diagnosis of subarachnoid hemorrhage and who have an intracranial pressure monitoring device.

Not a fit: Patients who are intubated and in a prone position, or those with severe cardiac or liver conditions, may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved management strategies for patients with subarachnoid hemorrhage, potentially reducing intracranial pressure and associated complications.

How similar studies have performed: While some studies have explored head positioning in related conditions, there is a lack of focused research on its effects on intracranial pressure specifically in subarachnoid hemorrhage patients, making this approach relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with subarachnoid hemorrhage confirmed by CT scan, MRI, or cerebral angiogram
* Age ≥ 18 years old
* Patients with intracranial pressure monitoring device
* Patients with continuous arterial blood pressure monitoring
* The subject or legally authorized representative must be available and able to consent

Exclusion Criteria:

* Intubated patients who are prone
* Patients with left ventricular ejection fraction \<20% as evidenced by echocardiogram previously documented at any time in the electronic medical record
* Patients with a diagnosis of pulmonary hypertension
* Patients with a diagnosis of cirrhosis and/or evidence of liver failure. Evidence of liver failure will be assessed by the presence of ascites, edema, abnormal lab values including low albumin, elevated PTT, elevated PT, elevated INR, or elevated bilirubin without another etiology, or MELD score \>8.
* Patients who are clinically unstable defined as those who are unable to lie flat for 30 minutes for any reason, patients on more than one continuous IV medications to increase blood pressure, or patients who are actively undergoing resuscitation.

Where this trial is running

Hershey, Pennsylvania

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Subarachnoid Hemorrhage, AneurysmalHemorrhage, SubarachnoidIntracranial Pressure
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.